Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1032220/000103222019000045/mms-20190331.htm
May 2022
May 2022
March 2022
February 2022
December 2021
November 2021
September 2021
August 2021
July 2021
June 2021
FOR IMMEDIATE RELEASE | CONTACT: | Lisa Miles 703.251.8637 | |
lisamiles@maximus.com | |||
Date: February 7, 2019 |
• | Revenue grew 7% to $664.6 million compared to $623.1 million reported for the same period last year, driven by the citizen engagement center acquisition in the U.S. Federal Services Segment |
• | Diluted earnings per share of $0.86 were better-than-expected due to strong operational delivery in the U.S. Health and Human Services Segment |
• | Cash flows from operations of $59.3 million and free cash flow of $53.9 million |
• | Year-to-date signed contract awards of approximately $224 million and contracts pending (awarded but unsigned) of approximately $743 million at December 31, 2018 |
• | Sales pipeline of $19.9 billion at December 31, 2018, of which 78% is new work |
• | Purchased 650,000 shares of MAXIMUS common stock for a total cost of $41.3 million for an average price of $63.52 |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1032220/000103222019000045/mms-20190331.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Maximus Inc.
Maximus Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Rating
Learn More![]()
We have a portfolio target operating profit margin that ranges between 10% and 15% with high cash conversion, a healthy balance sheet and access to a $400 million credit facility.
27 27 27 Our priorities for cash utilization are to actively pursue new growth opportunities, to maintain our quarterly dividend program and, where opportunities arise, to make purchases of our own shares.
This may be short term in nature and, over the life of the contract, we can improve revenue and profit through scope increases and operating efficiencies.
Cost-plus contracts typically have lower financial risk but typically earn margins in the mid-single digits.
The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as an alternative to revenue growth, cash flows from operations or net income as measures of performance.
For the second quarter of...Read more
Our Outside the U.S. Segment...Read more
Our U.S. Federal Services Segment...Read more
We have provided a reconciliation...Read more
Our U.S. Health & Human...Read more
Our cash flows from operations...Read more
This was offset by organic...Read more
We use our experience, business...Read more
Our Outside the U.S. Segment...Read more
Adjusted EBITDA is also a...Read more
These non-GAAP measures, as determined...Read more
The two largest acquired contracts...Read more
These services support a variety...Read more
Our contract portfolio offers us...Read more
At the acquisition date, the...Read more
The citizen engagement centers business...Read more
Our effective income tax rate...Read more
In addition to a payment...Read more
The second quarter of fiscal...Read more
This evaluation includes test work...Read more
Fluctuations in our SG&A; are...Read more
On a constant currency basis...Read more
We provide organic revenue growth...Read more
Our credit agreement includes the...Read more
Non-GAAP Measures We utilize non-GAAP...Read more
We believe that users of...Read more
Our interest expense is driven...Read more
If we had applied our...Read more
The second quarter of fiscal...Read more
As a result, revenue from...Read more
Our deep client relationships and...Read more
During the three months ended...Read more
We recorded amortization for intangible...Read more
Our SG&A; expense has increased...Read more
24 24 24 Our gross...Read more
These operating cash flows are...Read more
To calculate organic revenue growth,...Read more
As our general and administrative...Read more
Business Overview We are a...Read more
These costs may be incurred...Read more
Other factors which may cause...Read more
It is not unusual that...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Maximus Inc provided additional information to their SEC Filing as exhibits
Ticker: MMS
CIK: 1032220
Form Type: 10-Q Quarterly Report
Accession Number: 0001032220-19-000045
Submitted to the SEC: Thu May 09 2019 7:04:35 AM EST
Accepted by the SEC: Thu May 09 2019
Period: Sunday, March 31, 2019
Industry: Business Services